XNCR FY 2020 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$123M-21.7% YoY

Gross Profit

-$47M-38.4% margin

Operating Income

-$77M-62.6% margin

Net Income

-$69M-56.5% margin

EPS (Diluted)

$-1.11

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$19M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$703M

Total Liabilities

$131M

Stockholders' Equity

$572M

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$123M	$157M	-21.7%
Gross Profit	-$47M	$38M	-223.6%
Operating Income	-$77M	$14M	-655.5%
Net Income	-$69M	$27M	-358.0%